From the Journals

June 17, 2026

Indeterminate Thyroid Nodule Size May Predict RFA Success

In a functionally screened cohort, there was an 85% likelihood of being free of local treatment failure at 3 years, with outcomes favoring nodules smaller than 3 cm.

Conexiant

June 11, 2026

Medical Oddities: The Economics of Shut-Eye

Sleep became a commodity, tea became a therapy, and cats got a reprieve this week.

Conexiant

June 09, 2026

Lower BMI, Lower Joint Replacement Risk?

Researchers urge caution in interpreting joint replacement predictors, noting that surgery reflects access and decision-making as well as disease biology.

Conexiant

June 08, 2026

Shorter DAPT Tested Following CABG

TOP-CABG compared 3 months vs 12 months of ticagrelor plus aspirin following bypass surgery.

Conexiant

June 05, 2026

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

June 02, 2026

Consensus Guidance May Improve Sinonasal Mass Outcomes

Multidisciplinary recommendations emphasize biopsy technique, imaging, and pathology review in patients with suspected sinonasal malignancy.

Conexiant

June 01, 2026

Handwriting Kinematics Differentiate Cognitive Impairment

“Diagnostic differentiation emerged only under tasks imposing higher cognitive-motor demands.”

Conexiant

June 01, 2026

Cognition Associated With Future Depression Risk

Lower cognition is associated with later depression in controls, while higher cognition is associated with relapse in remitted depression

Conexiant

June 01, 2026

Can Proteomics Refine Lung Screening?

Proteomic biomarkers improve short-term lung cancer risk assessment.

Conexiant

May 29, 2026

AI Shows Promise for Intraoperative Lung Adenocarcinoma Assessment

A smartphone image–centered deep learning model showed promise for intraoperative diagnosis and grading of clinical stage IA lung adenocarcinoma, but grade-specific limitations and lack of outcomes data mean the tool remains investigational.

Conexiant

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

From the Journals

Indeterminate Thyroid Nodule Size May Predict RFA Success

Medical Oddities: The Economics of Shut-Eye

Lower BMI, Lower Joint Replacement Risk?

Shorter DAPT Tested Following CABG

OI Therapy Raised BMD, Not Fracture Benefit

Daily News

Consensus Guidance May Improve Sinonasal Mass Outcomes

Handwriting Kinematics Differentiate Cognitive Impairment

Cognition Associated With Future Depression Risk

Can Proteomics Refine Lung Screening?

AI Shows Promise for Intraoperative Lung Adenocarcinoma Assessment

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dentistry

ADA News

CDE World

New Dentist News

Conexiant

AACE Endocrinology AI

Conexiant

GI & Hepatology News

The ASCO Post

JADPRO

JNCCN

JNCCN 360

ASCO AI in Oncology

Glaucoma Physician

Ophthalmology Management

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

The Pathologist

From the Journals

Daily News

Recommendations